News & Publications

March 27, 2019 Hubrecht Organoid Technology and CrownBio announce a Strategic Partnership

 Press Release Hubrecht Organoid Technology and CrownBio Announce a Strategic Partnership on Oncology Organoid-Based Preclinical Drug Development and Validation Services     Utrecht, March 27, 2019 – Hubrecht Organoid Technology (HUB) and JSR Corporation the parent company, of Crown Bioscience, entered into a strategic partnership to provide preclinical oncology drug development and validation services using HUB Organoid Technology. As part of the agreement CrownBio, a wholly–owned subsidiary of JSR Corporation will expand its European presence by opening a new organoid–focused operational site in Utrecht, Netherlands.  The partnership brings … Continue reading Hubrecht Organoid Technology and CrownBio announce a Strategic Partnership

Read more

Posted by Tiny Klunder

February 25, 2019 HUB and Yamaha Motor Announce their Collaboration Combining their Proprietary Technologies

HUB and Yamaha Motor Announce their Collaboration Combining their Proprietary Technologies; HUB Organoid Technology AND Cell picking & imaging system CELL HANDLERTM   February 1, 2019 – Hubrecht Organoid Technology (HUB) and Yamaha Motor Co., Ltd. (Tokyo:7272) announced today their collaboration to provide solutions that deepen our understanding in predictive diagnostic of patients.   HUB … Continue reading HUB and Yamaha Motor Announce their Collaboration Combining their Proprietary Technologies

Read more

Posted by Tiny Klunder

January 31, 2019 Organoid course at MDIBL from May 26 to June 1

After our successful Organoid course last year, we would like to announce the launch of our next Organoid course on “Applications of Organoid Technology”. Please enroll on time as the course is in high demand. Time: 26th May-1st June 2019 Location: MDI Biological Laboratory in USA (Maine). Details on the course are available on the … Continue reading Organoid course at MDIBL from May 26 to June 1

Read more

Posted by Tiny Klunder

Long-term expanding human airway organoids for disease modeling

For the first time Clevers’ group successfully established long-term-expanding human airway organoids, containing all major cellular elements, from healthy individuals, as well as from patients. Several approaches have been explored to generate mammalian airway organoids. None of these approaches allows long-term expansion of airway epithelium from adult human individuals in vitro. Human airway organoids represent … Continue reading Long-term expanding human airway organoids for disease modeling

Read more

Posted by Tiny Klunder

December 3, 2018 Hans Clevers receives Erasmus Medal

We congratulate Hans Clevers for receiving the Erasmus Medal from the Academia Europaea Cardiff Knowledge Hub. The aim of the Academy is to promote European research, advise governments and international organisations in scientific matters, and further interdisciplinary and international research.

Read more

Posted by Tiny Klunder

August 3, 2018 The HUB is going to participate in the Drug Discovery 2018 Conference in London

Dr. Rob Vries, Managing Director at HUB, will be presenting at the  Drug Discovery 2018 conference, organized by the The European Laboratory Research & Innovation Group, to talk about organoids as sophisticated models for studying diseases and as robust emerging tools for precision medicine. This event will be live in London, October 9 & 10 at … Continue reading The HUB is going to participate in the Drug Discovery 2018 Conference in London

Read more

Posted by Tiny Klunder

July 15, 2018 HUB Announces Collaboration with Merck to Develop Organoid Models for Toxicology

Utrecht, Netherlands, June 29, 2018 – HUB today announced a collaboration with Merck that aims to determine the applicability of the HUB Organoids to study and predict nonclinical drug safety. The collaboration between Merck and HUB seeks to study intestinal toxicity using adult stem cell derived Organoids from different species, including human. HUB Organoids are … Continue reading HUB Announces Collaboration with Merck to Develop Organoid Models for Toxicology

Read more

Posted by Tiny Klunder

July 2, 2018 Stem-cell culture moves to the third dimension

Organoids, named “Method of the Year” last year by Nature Methods, are proving their worth in genetic disorders (e.g. CF), cancer research and drug development. Organoids are increasingly being used to study both normal development and the progression of diseases. Organoids are now  featuring together with Organs-On-Chip in this Nature article: Stem-cell culture moves to … Continue reading Stem-cell culture moves to the third dimension

Read more

Posted by Tiny Klunder